• 1. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives Chlorinated biphenyls

Introduction to 4-(3-Chloro-4-methoxyphenyl)-2-methoxybenzoic acid (CAS No. 1261905-01-4)

4-(3-Chloro-4-methoxyphenyl)-2-methoxybenzoic acid, identified by the CAS number 1261905-01-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of methoxybenzoic acids, a subgroup known for its diverse biological activities and potential therapeutic applications. The structural features of this molecule, particularly the presence of both chloro and methoxy substituents on the aromatic ring, contribute to its unique chemical properties and reactivity, making it a valuable scaffold for drug discovery and synthesis.

The 3-chloro-4-methoxyphenyl moiety in the compound's structure is particularly noteworthy, as it introduces a region of electrophilic character due to the electron-withdrawing effect of the chlorine atom alongside the electron-donating methoxy group. This balance of electronic effects makes the compound a versatile intermediate in organic synthesis, enabling various functionalization strategies that can be exploited in medicinal chemistry. The 2-methoxybenzoic acid backbone provides a stable aromatic system with hydrophilic properties, enhancing solubility and bioavailability in aqueous environments.

In recent years, there has been growing interest in methoxybenzoic acid derivatives as potential candidates for treating a range of diseases, including inflammation, neurodegenerative disorders, and metabolic syndromes. The specific arrangement of substituents in 4-(3-chloro-4-methoxyphenyl)-2-methoxybenzoic acid has been studied for its ability to modulate biological pathways by interacting with target enzymes and receptors. Preliminary studies suggest that this compound may exhibit anti-inflammatory properties by inhibiting key pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, its structural similarity to known pharmacophores has prompted investigations into its potential as an antioxidant agent.

The chemical synthesis of 4-(3-chloro-4-methoxyphenyl)-2-methoxybenzoic acid involves multi-step reactions that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include Friedel-Crafts acylation followed by selective methylation and chlorination. Advances in catalytic methods have enabled more efficient and sustainable production processes, reducing waste and improving scalability. These developments are critical for translating laboratory findings into viable pharmaceutical candidates.

From a medicinal chemistry perspective, the compound's dual methoxy substituents provide opportunities for further derivatization to optimize pharmacokinetic profiles. For instance, modifications at the carboxylic acid group can enhance binding affinity or metabolic stability, while alterations at the aromatic ring can fine-tune selectivity against specific biological targets. Computational modeling techniques, such as molecular docking and quantum mechanics calculations, have been employed to predict how 4-(3-chloro-4-methoxyphenyl)-2-methoxybenzoic acid interacts with biological systems. These virtual screening approaches have accelerated the identification of promising analogs for experimental validation.

Current research is exploring the potential of this compound in neuroprotective therapies, where its ability to cross the blood-brain barrier may be leveraged to address neuroinflammatory conditions like Alzheimer's disease or Parkinson's disease. Studies indicate that methoxybenzoic acid derivatives can modulate microglial activation—a key pathological feature in these disorders—by influencing signaling pathways such as NF-κB and MAPK. Furthermore, the compound's structural resemblance to natural products like curcumin suggests it may enhance endogenous antioxidant defenses against oxidative stress-induced neuronal damage.

The pharmacokinetic properties of 4-(3-chloro-4-methoxyphenyl)-2-methoxybenzoic acid are also under investigation to determine its suitability for clinical applications. Preliminary pharmacokinetic studies suggest moderate oral bioavailability coupled with reasonable tissue distribution, indicating potential for systemic therapy. However, challenges such as rapid metabolism or poor solubility may necessitate formulation strategies like prodrugs or nanoparticles to improve delivery efficiency. These considerations are essential for advancing from preclinical findings to human trials.

In conclusion,4-(3-chloro-4-methoxyphenyl)-2-methoxybenzoic acid (CAS No. 1261905-01-4) represents a promising candidate in pharmaceutical research due to its unique structural features and demonstrated biological activity. Ongoing studies continue to unravel its mechanisms of action across multiple therapeutic areas while refining synthetic methodologies for large-scale production. As our understanding of molecular interactions evolves,this compound will likely remain at forefront of drug discovery efforts aimed at addressing complex human diseases through targeted molecular intervention.

• 22775-37-7(3,5-Dichloro-2-methoxybenzoic acid)
• 23053-81-8(5-Chloro-2,4-dimethoxy-benzoic Acid)
• 146984-79-4(3-Chloro-6-hydroxy-2-methoxybenzoic acid)
• 107517-12-4([1,1'-Biphenyl]-4-carboxylicacid, 3'-chloro-2'-methoxy-)
• 36809-08-2(2-(2-Chlorophenoxy)-benzoic acid)
• 3187-20-0(3-Chlor-2-hydroxy-4,6-dimethoxy-benzoesaeure)
• 3260-93-3(3-Chloro-2-methoxybenzoic acid)
• 36335-47-4(Benzoic acid,3-chloro-2,6-dimethoxy-)
• 88086-65-1(Benzoic acid, 2-(4-carboxyphenoxy)-3-chloro-)
• 1000025-59-1(4-(4-chlorophenyl)-2-methoxybenzoic Acid)